FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4074401000001100: Report all adverse reactions to the CSM (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
10072501000001113 Report all adverse reactions to the CSM en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36829301000001115 Report all adverse reactions to the CSM (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Report all adverse reactions to the CSM Is a CSM warning status messages true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Memantine hydrochloride 10mg/g oral drops - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Memantine hydrochloride 10mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Glatiramer acetate 20mg injection (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Copaxone 20mg injection (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sibutramine hydrochloride monohydrate 15mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sibutramine hydrochloride monohydrate 10mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Reductil 10mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Reductil 15mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
OctreoScan[In111] injection kit CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Pentetreotide+indium chloride[111In] 10micrograms/111MBq/mL injection kit - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
TechneScan MAG3 labelling kit CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Solvent+detergent (SD) treated Frozen Human Plasma intravenous solution - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Okacyn 0.3% eye drops CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Noritate 1% cream CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
NovoRapid Penfill 100units/mL cartridge CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
NovoRapid NovoLet 100units/mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Remicade 100mg infusion concentrate (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Infliximab 100mg infusion concentrate (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Risperidone 25mg powder+solvent for suspension for injection - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Risperidone 37.5mg powder+solvent for suspension for injection - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Risperidone 50mg powder+solvent for suspension for injection - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Risperdal Consta 50mg powder+solvent for suspension for injection CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Risperdal Consta 37.5mg powder+solvent for suspension for injection CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Risperdal Consta 25mg powder+solvent for suspension for injection CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Losec 40mg i-v infusion (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Omeprazole 40mg i-v infusion (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Losec 40mg injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Omeprazole 40mg injection (pdr for recon)+solvent - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Protopic 0.1% ointment CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Protopic 0.03% ointment CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sulphur hexafluoride 40microlitres injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Dovobet ointment CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Lumigan 0.3mg/mL eye drops CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
NovoRapid FlexPen 100units/mL prefilled pen CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Varilrix vaccine injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Lantus 100iu/mL OptiSet prefilled pen CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Lantus 100iu/mL injection vial CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Lantus 100iu/mL injection cartridge CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Silkis 3micrograms/g ointment CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Hiberix vaccine injection (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Kineret 100mg/0.67mL injection prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Anakinra 100mg/0.67mL injection prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sirolimus 2mg/sachet oral solution CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sirolimus 1mg/sachet oral solution CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sirolimus 1mg/mL oral solution - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Product containing precisely sirolimus 1 milligram/1 each conventional release oral tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rapamune 1mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Amifostine 375mg injection (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ethyol 375mg injection (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ethyol 500mg injection (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Amifostine 500mg injection (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rapamune 2mg/sachet oral solution CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rapamune 1mg/sachet oral solution CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rapamune 1mg/mL oral solution CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Mycophenolate mofetil 500mg infusion concentrate (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
CellCept 1g/5mL oral suspension CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Mycophenolate mofetil 1g/5mL oral suspension CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
CellCept 500mg infusion concentrate (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
CellCept 500mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Mycophenolate mofetil 500mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
CellCept 250mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Mycophenolate mofetil 250mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Herceptin 150mg infusion concentrate (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Mabthera 500mg/50mL infusion concentrate CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Mabthera 100mg/10mL infusion concentrate CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rituximab 500mg/50mL infusion concentrate - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rituximab 100mg/10mL infusion concentrate - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Exemestane 25mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aromasin 25mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Daclizumab 25mg/5mL infusion concentrate - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Zenapax 25mg/5mL infusion concentrate CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Peginterferon alfa-2b 120micrograms injection (pdr for recon)+solvent - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Peginterferon alfa-2b 150micrograms injection (pdr for recon)+solvent - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Peginterferon alfa-2a 180micrograms/0.5mL solution for injection prefilled syringe - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Peginterferon alfa-2a 135micrograms/0.5mL solution for injection prefilled syringe - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
ViraferonPeg 150micrograms powder+solvent for solution for injection in prefilled pen CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
ViraferonPeg 120micrograms powder+solvent for solution for injection in prefilled pen CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
ViraferonPeg 100micrograms powder+solvent for solution for injection in prefilled pen CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
ViraferonPeg 80micrograms powder+solvent for solution for injection in prefilled pen CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
ViraferonPeg 50micrograms powder+solvent for solution for injection in prefilled pen CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Pegasys 135micrograms/0.5mL solution for injection prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Foscan 20mg/5mL solution for injection CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Temoporfin 20mg/5mL solution for injection - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Bexarotene 75mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Targretin 75mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Imatinib 100mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Glivec 100mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Alemtuzumab 30mg/3mL infusion concentrate CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
MabCampath 30mg/3mL infusion concentrate CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Trastuzumab 150mg infusion concentrate (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Pegasys 180micrograms/0.5mL solution for injection prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
ViraferonPeg 150micrograms injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
ViraferonPeg 120micrograms injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
PegIntron 150micrograms injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier

Start Previous Page 6 of 8 Next End

This concept is not in any reference sets

Back to Start